Background: Adrenocortical carcinoma (ACC) is a rare malignant disease with a poor prognosis. Our aims were to study survival and to explore prognostic markers. Methods: We retrospectively ...

[15] An ongoing, multicenter study -- the First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment [18] (FIRM-ACT; www.firm-act.org) -- will ...

LAS VEGAS , NV, UNITED STATES, February 5, 2025 /EINPresswire / -- DelveInsight's“Adrenocortical Carcinoma market Insights, Epidemiology, and Market Forecast-2034” report offers an in-depth ...

Medically reviewed by Kelly Wood, MDMedically reviewed by Kelly Wood, MD Adrenal cancer occurs when a malignant (cancerous) ...

We have a deep understanding of how to evaluate your condition and how select and combine treatments to get the best possible results — even for rare cancers that many doctors in the community never ...

which was initially misidentified as adrenocortical carcinoma due to its size. This case illustrates the diagnostic difficulties associated with adrenal schwannomas and the importance of ...

However, the adrenal nodule requires evaluation for possible excess hormone production or suspicion of cancer. A pheochromocytoma is a tumor that produces adrenaline. Adrenaline is commonly associated ...

Collaboration to take Cytovation's synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma <li /> Ca ...